140 related articles for article (PubMed ID: 16437154)
1. A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22).
Kim M; Lim J; Kim Y; Han K; Kang CS; Kim HJ; Min WS
Leukemia; 2006 Apr; 20(4):746-8. PubMed ID: 16437154
[No Abstract] [Full Text] [Related]
2. Isolated granulocytic sarcoma followed by acute myelogenous leukemia type FAB-M2 associated with inversion 16 and trisomies 9 and 22.
Morel F; Herry A; Le Bris MJ; Le Calvez G; Marion V; Berthou C; De Braekeleer M
Leukemia; 2002 Dec; 16(12):2458-9. PubMed ID: 12454755
[No Abstract] [Full Text] [Related]
3. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
[TBL] [Abstract][Full Text] [Related]
4. Faggot cells in an HIV-positive patient with inv(16)/therapy-related acute myeloid leukaemia.
Jerez A; del Mar Osma M; Amigo M; Ortuño FJ
Br J Haematol; 2010 Sep; 150(6):646. PubMed ID: 20666775
[No Abstract] [Full Text] [Related]
5. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
[TBL] [Abstract][Full Text] [Related]
6. Secondary acute leukemia with 'favorable' cytogenetic abnormalities.
Martín-Henao GA; Aventín A
Leukemia; 1994 Aug; 8(8):1440. PubMed ID: 8057686
[No Abstract] [Full Text] [Related]
7. A case of therapy-related acute lymphoblastic leukemia with t(9;22)(q34;q11.2) following treatment of breast cancer.
Tazi I; Nafil H; Mahmal L; Elomrani A; Khouchani M; Tahri A; Hda N
Leuk Res; 2011 May; 35(5):e58. PubMed ID: 21247633
[No Abstract] [Full Text] [Related]
8. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
Venugopal P; Manson S; Preisler HD
Cancer Treat Res; 2001; 108():257-65. PubMed ID: 11702603
[No Abstract] [Full Text] [Related]
9. Therapy-related, donor-derived AML responding to a second allogeneic BMT.
Jacobs JF; Brons PP; Simons A; van der Reijden BA; Hoogerbrugge PM
Bone Marrow Transplant; 2007 Sep; 40(5):499-500. PubMed ID: 17589531
[No Abstract] [Full Text] [Related]
10. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
[TBL] [Abstract][Full Text] [Related]
11. Near-tetraploid acute myeloid leukemia after allogeneic bone marrow transplantation.
Laurenti L; d'Onofrio G; Zini G; Sica S; Chiusolo P; Leone G
Haematologica; 2000 Apr; 85(4):432-4. PubMed ID: 10756374
[No Abstract] [Full Text] [Related]
12. inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.
Schmidt HH; Pirc-Danoewinata H; Linkesch W; Strunk D; Wieser R
Haematologica; 2003 Dec; 88(12):ECR38. PubMed ID: 14688011
[No Abstract] [Full Text] [Related]
13. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M
Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
Perea G; Lasa A; Aventín A; Domingo A; Villamor N; Queipo de Llano MP; Llorente A; Juncà J; Palacios C; Fernández C; Gallart M; Font L; Tormo M; Florensa L; Bargay J; Martí JM; Vivancos P; Torres P; Berlanga JJ; Badell I; Brunet S; Sierra J; Nomdedéu JF;
Leukemia; 2006 Jan; 20(1):87-94. PubMed ID: 16281071
[TBL] [Abstract][Full Text] [Related]
15. Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely.
Martinelli G; Buonamici S; Visani G; Malagola M; Piccaluga PP; Isidori A; Bosi C; Bonifazi F; Soverini S; Terragna C; Amabile M; Giannini B; Baccarani M
Leukemia; 2003 Mar; 17(3):650-1; author reply 651-2. PubMed ID: 12646962
[No Abstract] [Full Text] [Related]
16. [Bulky lymphadenopathy in acute myeloid leukemia with inv (16) (p13q22): a case report].
Zhou HF; Li JY; Qian SX; Qiu HR; Zhang SJ; Zhang JF; Wu YJ; Shen RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1033-7. PubMed ID: 17096914
[TBL] [Abstract][Full Text] [Related]
17. Long-term disease-free acute myeloblastic leukemia with inv(16) is associated with PCR undetectable CBFbeta/MYH11 transcript.
Martinelli G; Ottaviani E; Testoni N; Montefusco V; Pastano R; Tura S
Haematologica; 2000 May; 85(5):552-5. PubMed ID: 10800179
[No Abstract] [Full Text] [Related]
18. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
[TBL] [Abstract][Full Text] [Related]
19. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
[TBL] [Abstract][Full Text] [Related]
20. Acute leukemia presenting a variant Ph chromosome with p190 expression, dup 3q and -7, developed after malignant lymphoma treated with alkylating agents and topoisomerase II inhibitors.
Alimena G; Cedrone M; Nanni M; De Cuia MR; Lo Coco F; De Sanctis V; Cimino G; Mancini M
Leukemia; 1995 Sep; 9(9):1483-6. PubMed ID: 7658716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
